Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Papillomavirus Infections 3 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Precancerous Conditions 1

Interventions

Peripheral Blood Stem Cell Transplantation 9 Cyclophosphamide 9 Biopsy 8 fludarabine phosphate 7 Whole-Body Irradiation 6 Tacrolimus 5 Mycophenolic Acid 5 Epoetin Alfa 5 Colposcopy 5 Celecoxib 5 Busulfan 5 Aminolevulinic Acid 5 Sulindac 4 Selenium 4 Methotrexate 4 Melphalan 4 Cyclosporine 4 Cetuximab 4 Antilymphocyte Serum 4 Polymerase Chain Reaction 3 Imiquimod 3 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3 Gene Expression Profiling 3 Etoposide 3 Eflornithine 3 Darbepoetin alfa 3 Carboplatin 3 Aspirin 3 fludarabine 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Precancerous Conditions × artemisinin × Clear all

NCT03100045 2021-11-03

ART-AIN

Johns Hopkins University

Phase 1 Completed

Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡